Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Aging Neuroscience|October 23, 2019
Role of Microglial Cells in Alzheimer's Disease Tau PropagationEna Španić, Lea Langer Horvat, Patrick R Hof, et al.
Progress in Molecular Biology and Translational Science|November 9, 2019
Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's diseaseGoran Šimić, Ena Španić, Lea Langer Horvat, et al.
Cells|July 27, 2022
NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal LossEna Španić, Lea Langer Horvat, Katarina Ilić, et al.
Biomedicines|May 16, 2023
Metals in Alzheimer's DiseaseMirjana Babić Leko, Lea Langer Horvat, Ena Španić Popovački, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 17, 2025
Biochemical characterization of Tau protein changes and amyloid dynamics in a novel non-transgenic rat model of tauopathyLea Langer Horvat, Ena Španić Popovački, Mirjana Babić Leko, et al.
Biomedicines|May 16, 2023
Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy ModelLea Langer Horvat, Ena Španić Popovački, Mirjana Babić Leko, et al.
Neurology International|July 25, 2023
Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer's DiseaseEna Španić Popovački, Mirjana Babić Leko, Lea Langer Horvat, et al.
Current Alzheimer Research|September 13, 2018
Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's DiseaseMirjana Babić Leko, Magdalena Krbot Skorić, Nataša Klepac, et al.
International Journal of Molecular Sciences|June 26, 2025
Quercetin as a Therapeutic Option in a Rat Model of Aluminum Chloride- and D-Galactose-Induced NeurodegenerationMarina Kukolj, Nada Oršolić, Lea Langer Horvat, et al.
CNS Neuroscience & Therapeutics|February 18, 2018
Evaluation of cerebrospinal fluid phosphorylated tau<sub>231</sub> as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementiaSpomenka Kiđemet-Piskač, Mirjana Babić Leko, Antonela Blažeković, et al.
Pageof 2